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A B S T R A C T
The introduction of a hydroxy group to the cholesterol skeleton introduces not only the possibility for
positional isomers but also diastereoisomers, where two or more isomers have different conﬁgurations at
one or more of the stereocentres but are not mirror images. The differentiation of diastereoisomers is
important as differing isomers can have differing biochemical properties and are formed via different
biochemical pathways. Separation of diasterioisomers is not always easy by chromatographic methods
Here we demonstrate, by application of charge-tagging and derivatisation with the Girard P reagent, the
separation and detection of biologically relevant diastereoisomers using liquid chromatography  mass
spectrometry with multistage fragmentation.
© 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The most commonly observed diastereoisomers derived from
cholesterol are 7a-hydroxycholesterol and 7b-hydroxycholesterol
(7a-HC and 7b-HC). These can be formed via free radical oxidation
by initial abstraction of the C-7 hydrogen followed by reaction with
oxygen to form a peroxyradical, hydrogen abstraction to form a
peroxide and ultimately reduction to 7a- or 7b-HC (Murphy and
Johnson, 2008) (Fig. 1). These reactions may proceed in air during
sample handling or in the biological systems, e.g. in the lysosomal
storage disease Niemann Pick type C (NPC) (Alvelius et al., 2001).
7a-HC is also formed enzymatically from cholesterol by the
enzyme cytochrome p450 7A1 (CYP7A1) in the ﬁrst step of the
neutral pathway of bile acid biosynthesis (Russell, 2003), while
7b-HC can be formed from 7-oxocholesterol (7-OC) in a reaction
catalysed by hydroxysteroid dehydrogenase 11B1 (HSD11B1) (Hult
et al., 2004; Larsson et al., 2007; Mitic et al., 2013). 7-OC can be
formed from the cholesterol precursor 7-dehydrocholesterol (7-
DHC) in a reaction also catalysed by CYP7A1 (Shinkyo et al., 2011)
and also by a free radical oxidation mechanism from cholesterol
(Fig. 1). Both 7-OC and 7b-HC are abundant in the disease Smith
Lemli Opitz Syndrome (SLOS) where 7-DHC, the CYP7A1 substrate,
is present at elevated concentrations (Grifﬁths et al., 2016). To
understand the origin of 7a-HC and 7b-HC it is necessary to
differentiate between them. While the epimers 7a-HC and 7b-HC
can be resolved by gas chromatography (GC) (Dzeletovic et al.,
1995) this is not always the case with liquid chromatography (LC)
(McDonald et al., 2012).
Less commonly considered diastereoisomers are 24S- and 24R-
hydroxycholesterols (24S-HC and 24R-HC). 24S-HC is formed from
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Fig. 1. Formation of 7-hydroxycholesterol (7-HC) and 7-oxocholesterol (7-OC) by radical initiated and enzymatic reactions. LOO. corresponds to a lipid hydroperoxy radical
and LOH to a hydroxy lipid. Enzyme catalysed reactions are shown in the blue boxes and radical initiated pathways in the red box. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Reconstructed-ion chromatograms (RICs) displaying how 7a-HC, 7b-HC, 7a-HCO and 7-OC vary in plasma in health and disease and according to sample storage. (A)
RIC from NIST SRM1950 plasma treated with cholesterol oxidase and (B) in the absence of cholesterol oxidase. (C) RIC from a typical CTX plasma sample treated with
cholesterol oxidase and (D) in the absence of cholesterol oxidase. (E) RIC from a typical SLOS plasma sample treated with cholesterol oxidase and (F) in the absence of
cholesterol oxidase. (G) RIC from a dried plasma sample, transported to Swansea from Germany without precaution being taken against oxidation in air, treated with
cholesterol oxidase and (H) in the absence of cholesterol oxidase. Aliquots of sample prepared in the presence of cholesterol oxidase were derivatised with [2H5]GP and those
prepared in the absence of cholesterol oxidase with [2H0]GP. Analyte concentrations are given in supplementary Table S1 (Crick et al., 2015b; Grifﬁths et al., 2016, 2013a;
Theoﬁlopoulos et al., 2014).
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cholesterol by the enzyme CYP46A1, predominantly expressed in
neurons in brain, however, the origin of 24R-HC is less well
established (Russell, 2003). Most GC-mass spectrometry (MS)
methods are not optimised to differentiate between these epimers
and it is generally assumed that all 24-HC detected is the 24S-
epimer. This may not necessarily be the case.
A further stereocentre of biological importance is at C-25.
During bile acid biosynthesis side-chain shortening in the
peroxisome the stereochemistry at C-25 of the C27 acid is changed
from R to S by the enzyme alphamethylacyl-CoA racemase
(AMACR). This is necessary for the next step in the pathway,
catalysed by the peroxisomal enzyme acyl-coenzyme A oxidase 2
(ACOX2), which introduces a double bond between C-24 and C-25,
to proceed and ultimately lead to a C24 acid (Russell, 2003). When
found in plasma, cholestenoic acids are usually assumed to have R
stereochemistry at C-25.
Here we describe how we have optimised the charge-tagging
technique christened enzyme-assisted derivatisation for steroid
analysis (EADSA) (Grifﬁths et al., 2013b) to separate and identify
oxysterol, cholestenoic and cholenoic acid diastereoisomers.
2. Materials and methods
2.1. Materials
Human serum and plasma samples were from waste material
from previous studies in Swansea (Abdel-Khalik et al., 2017) or
supplied by the Reference Institute for Bioanalytics, Bonn,
Germany as a reference material for interlaboratory comparison
of oxysterol measurements (Lütjohann et al., 2014). Written
informed consent was obtained from all subjects in accordance
with the Declaration of Helsinki. The study was conducted with
institutional review board approval. The NIST standard reference
material (SRM1950) was by prepared by NIST from plasma samples
from 100 individuals between 40 and 50 years of age, whose
ethnicity was representative of the US population and that
included an equal number of men and women (Gaithersburg,
MD) (Quehenberger et al., 2010).
All reagents were from sources documented in (Crick et al., 2015a,
2015b). Oxysterol, cholestenoic and cholenoic acid authentic
standard were from Avanti Polar Lipids Inc (Alabaster, AL) or from




To enhance sensitivity, solubility in solvents used in reversed-
phase chromatography and to enrich structure-informative frag-
mentation we employed EADSA. In brief, after separation of
oxysterols and C24 and C27 acids from cholesterol and other
hydrophobic sterols, an aliquot (A) of the oxysterol fraction
containing the acids was oxidised with cholesterol oxidase from
Streptomycessp (Sigma-Aldrich,Dorset,UK) to convert 3b-hydroxy-
5-ene structures to 3-oxo-4-enes. The oxo groups were then reacted
with the Girard P reagent (GP) to generate GP-hydrazones which
wereseparatedfromexcessreagentsonanOASISHLBreversedphase
solid phase extraction column (Waters, Elstree, UK). As some
oxysterols naturally contain a 3-oxo-4-ene group e.g. 7a-hydrox-
ycholest-4-en-3-one (7a-HCO), to avoid confusion with those
oxidised by cholesterol oxidase to contain this function a separate
aliquot of sample (B) was prepared in an identical fashion but in the
absence of cholesterol oxidase. To allow the simultaneous analysis of
aliquots (A) and (B), [2H5]GP was used to derivatise aliquots (A) and
[2H0]GP to derivatise aliquots (B). The two aliquots were combined
immediately before LC–MS analysis. Oxysterols derivatised with
[2H5]GP will have a mass 5.0314 Da heavier than those derivatised
with [2H0]GP. Note an alkaline hydrolysis step was not performed so
free were oxysterols analysed not total oxysterols.
2.2.2. LC–MSn
Derivatised oxysterols and C24 and C27 acids were separated on
a Hypersil Gold reversed phase column (Thermo-Fisher Scientiﬁc,
Hemel Hempstead, UK) as described in (Crick et al., 2015b) and
Fig. 3. MS3 ([M+! [M-Py]+! ) spectra of (A) 7b-HC, (B) 7a-HC and (C) 7-OC.
Aliquots of sample prepared in the presence of cholesterol oxidase were derivatised
with [2H5]GP and those prepared in the absence of cholesterol oxidase with [2H0]GP.
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Fig. 4. Fragmentation of 7-hydroxycholesterols. Ions of elevated relative abundance in the spectra of 7a- and 7b- epimers are indicated by arrows.
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analysed by electrospray ionisation (ESI)  MS and MS with
multistage fragmentation (MSn) on an Orbitrap Elite hydride linear
ion trap (LIT)  Orbitrap mass spectrometer (Thermo-Fisher
Scientiﬁc, Hemel Hempstead, UK). While the Orbitrap performed
m/z scans at high resolution (120,000 full-width at half height
deﬁnition) the LIT simultaneously performed MS3 scans on
preselected precursor and product-ions.
3. Results
3.1. LC separation and MSn fragmentation
As discussed previously (Crick et al., 2015b), GP-derivatised
oxysterols fragment in the ﬁrst MS/MS event (MS2) with the loss of
the pyridine ring to give the [M-Py]+ fragment, [M-84]+ for [2H5]GP
and [M-79]+ for [2H0]GP. [M-Py]+ ions then fragment in an MS3
(MS/MS/MS) event to give structurally informative fragment-ions
showing cleavage in the ring-system, side-chain and with loss of
H2O and CO and combinations thereof.
3.1.1. 7a-HC, 7b-HC and 7a-HCO
7a-HC and 7b-HC are chromatographically resolved in our
system (Fig. 2A). The introduction of a polar hydroxyl group to the
non-polar b-face of the sterol ring system reduces its hydropho-
bicity and retention on a C18 reversed-phase column. A
reconstructed ion chromatogram (RIC,  5 ppm) from a typical
serum sample is shown in Fig. 2A. Both 7b-HC and 7a-HC give
double peaks as a consequence of syn and anti conformers of the
GP-derivative. The RIC in Fig. 2A is for the aliquot treated with
cholesterol oxidase and derivatised with [2H5]GP. Fig. 2B shows the
chromatogram generated from aliquot B in the absence of
cholesterol oxidase and derivatised with [2H0]GP. This chromato-
gram reveals compounds with a natural oxo group, i.e. 7a-HCO and
7-OC. While 7a-HCO can be formed in vivo from 7a-HC by HSD3B7
(Fig. 1), 7b-HCO is not formed from 7b-HC by this enzyme (Furster
et al., 1996) and is thus absent. This, beside chromatographic
resolution and differing MS3 spectra (see below), provides further
evidence for the identity of the peaks assigned to the 7b-hydroxy
epimer in chromatogram 2A. Absolute conﬁrmation of identity
was made by comparison with authentic standards. As peaks in
aliquot (A) correspond to the sum of both 3b-hydroxy-5-ene and
3-oxo-4-ene compounds, while those in the (B) aliquot just to oxo
compounds, quantiﬁcation of 3b-hydroxy-5-ene compounds is
easily performed by subtracting concentrations determined for a
peak in (B) from those determined for the equivalent peak in (A).
Concentration determined for peaks in (B) are those for the natural
oxo compounds.
The MS3 spectra of 7b-HC and 7a-HC/7a-HCO are similar but
not identical (Fig. 3). The 7a-hydroxy group is more labile with the
result that the [M-Py-18]+ fragment-ion (m/z 437, Fig. 4) dominates
Fig. 5. Separation and fragmentation of 24S-HC and 24R-HC. (A) RIC for 24S-HC and 24R-HC using a 37 min gradient. Other peaks correspond to 22R-HC and 7a-HC. The
hydroxycholesterols (HCs) are heavy isotope labelled with [25,26,26,26,27,27,27-2H7] and derivatised with [2H5]GP. (B) MRM chromatogram for the [M]+! [M-
Py]+! 353.3  0.3 transition. 22R-HC also shows a fragment ion at m/z 353.3 (see Supplementary Fig. S1A). (C) RIC for monohydroxycholesterols in a typical human serum
sample and (D) MRM chromatogram for the [M]+! [M-Py]+! 353.3  0.3 transition, highlighting 24-HC, in the same sample. (E) RIC for HCs in a CTX plasma sample using a
17 min gradient. (F) MRM chromatogram for the [M]+! [M-Py]+! 353.3  0.3 transition from the CTX patient using the 17 min gradient (Crick et al., 2015b). (G) RIC for [2H7]
24S-HC and [2H7]24R-HC using the 17 min gradient. (H) MS3 ([M+! [M-Py]+!) spectra of [2H7]24S-HC and (I) [2H7]24R-HC. Note in the spectra of the [2H7]24-HC molecules
fragment ions are observed at m/z 444, 434, 416 and 401 which are 7 Da heavier than equivalent fragment ions in the [2H0]24-HC native molecules (see Supplementary
Fig. S1C & S1F and Fig. 6). Analyte concentrations are given in supplementary Table S1.
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the MS3 spectrum and the [M-Py-28-18-15]+ (m/z 394) and *c2 + 2-
18 (m/z 231) fragment-ions are of greater relative abundant than in
the MS3 spectrum of 7b-HC. On the other hand, the [M-Py-28]+ (m/
z 427) and *b1-12 (m/z 151) fragment-ions are of higher relative
abundance in the spectrum of 7b-HC than 7a-HC (Figs. 3A and B &
4).
The abundance of 7a-HC and 7b-HC are of diagnostic value.
One example is cerebrotendinous xanthomatosis (CTX) where the
Fig. 6. Fragmentation of 24-hydroxycholesterols.
74 W.J. Grifﬁths et al. / Chemistry and Physics of Lipids 207 (2017) 69–80
enzyme CYP27A1 is deﬁcient resulting in reduced levels of its
product (25R)26-hydroxycholesterol ((25R)26-HC) and greatly
elevated levels of 7a-HC and 7a-HCO in plasma (Fig. 2C and D)
(DeBarber et al., 2011). In SLOS where both 7-DHC and 7-OC are
elevated in plasma so is 7b-HC formed from 7-OC by HSD11B1
(Fig. 2E and F). A complication when using 7-HC epimers or 7-OC in
disease diagnosis is that each can be formed in air by reaction with
oxygen (Fig. 2G and H) (Schroepfer, 2000).
3.1.2. 24S-HC and 24R-HC
24S-HC elutes before 24R-HC (Fig. 5A–D & E–G showing two
different gradients). They give an essentially identical MS3
spectrum where the fragment ion ‘*f at m/z 353 is prominent
(Figs. 5 H and I & 6 ). This ion is very minor in closely eluting 25-
hydroxycholesterol (25-HC) and (25R)26-HC (see Supplementary
Fig. S1). By performing a RIC for m/z 353 in the MS3 chromatogram
to give a multiple reaction monitoring (MRM) chromatogram for
transitions [M]+! [M-Py]+! 353 the 24-HC epimers are
highlighted. This is demonstrated for [25,26,26,26,27,27,27-2H7]
24S-HC and [25,26,26,26,27,27,27-2H7]24R-HC authentic standards
in Fig. 5B (MS3 spectra shown in Fig. 5H and I) and in a typical
human serum sample in Fig. 5D and in a CTX plasma sample in
Fig. 5F. The fragmentation pattern for the endogenous molecule is
described by Fig. 6 and its MS3 spectrum shown in supplementary
Fig. S1. Quantiﬁcation can be performed using the MRM
chromatograms for the authentic standard and endogenous
molecules.




(7aH,3O-CA(25R)) acids are found in plasma (Fig. 7A and B).
They can be formed via both the neutral and acidic pathways of
bile acid biosynthesis (Russell, 2003). Once a 7a-hydroxy group is
present on the B-ring, the sterol becomes a substrate for HSD3B7
and the 3b-hydroxy-5-ene is converted to a 3-oxo-4-ene. Both
acids when derivatised give double peaks corresponding to syn
and anti conﬁrmers of the GP-hydrazone. Surprisingly, in plasma a
quartet rather than a doublet of peaks is observed in the
appropriate RIC, each giving an identical MS3 spectrum (Fig. 7D
and E). Custom synthesis of [2H2]-labelled 25R and 25S epimers
(supplementary Fig. S2) showed that the smaller peaks of the
quartet correspond to the 25S epimers, 3b,7a-diHCA(25S) and
7aH,3O-CA(25S), while the larger peaks correspond to the 25R
epimers.
Further possible diastereomers are 3b,7b-dihydroxycholest-5-
en-(25R)26-oic (3b,7b-diHCA(25R)) and 3b,7b-dihydroxycholest-
5-en-(25S)26-oic (3b,7b-diHCA(25S)). As HSD3B7 is not active on
sterols with a 7b-hydroxy group the 7b-hydroxy-3-oxo-4-ene
acids are not expected to present endogenously (Furster et al.,
1996). Close scrutiny of the RIC shown in Fig. 7A reveals a peak
with retention time and giving an MS3 spectrum (Fig. 7C) identical
to the 3b,7b-diHCA(25R) authentic standard. This peak is absent in
Fig. 7B where the sample was prepared in the absence of
cholesterol oxidase. In keeping with the MS3 spectra of 7a-HC
and 7-bHC, the [M-Py-18]+ ion at m/z 467 dominates the spectrum
of the 7a-epimers, with the [M-Py-28-18-15]+ (m/z 424) and
*c2 + 2-18 (m/z 231) being of greater relative abundance than in the
spectrum of the 7b-epimer (Fig. 8). On the other hand the
fragment ions [M-Py-28]+ (m/z 457) and *b1-12 (m/z 151) are of
greater relative abundance in the spectrum of the 7b-epimer. An
early eluting shoulder can be observed on the chromatographic
peak assigned to the 3b,7b-diHCA(25R) diastereomer. This
Fig. 7. Separation and fragmentation of diastereoisomers of 3,7-dihydroxycholest-
5-en-26-oic and 7-hydroxy-3-oxocholest-4-en-26-oic acids. (A) RIC from NIST
SRM1950 plasma showing the separation of 3b,7b-diHCA(25S), 3b,7b-diHCA(25R),
3b,7a-diHCA(25S) and 3b,7a-diHCA(25R). Peak intensities in the time window 3–
5 min have been multiplied by 2. (B) The 3b,7b-diHCA epimers are not substrates
for HSD3B7 so do not give 7bH,3O-CA compounds, while 3b,7a-diHCA are and give
7aH,3O-CA epimers. (C) MS3 ([M]+! [M-Py]+! ) spectra of 3b,7b-diHCA(25R), (D)
3b,7a-diHCA(25S) and (E) 3b,7a-diHCA(25R). Aliquots of sample prepared in the
presence of cholesterol oxidase were derivatised with [2H5]GP and those prepared
in the absence of cholesterol oxidase with [2H0]GP. Analyte concentrations are given
in supplementary Table S1.
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Fig. 8. Fragmentation of 3b,7a-diHCA and 3b,7b-diHCA. Ions of elevated relative abundance in the spectra of 7a- and 7b- epimers are indicated by arrows.
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Fig. 9. Separation and fragmentation of diastereoisomers of 3,7-dihydroxychol-5-en-24-oic and 7-hydroxy-3-oxochol-4-en-24-oic acids. (A) RIC from NIST SRM1950 plasma
showing the separation of 3b,7b-diH-D5-BA and 3b,7a-diH-D5-BA. (B) The 3b,7b-diH-D5-BA is not a substrate for HSD3B7 so does not give 7bH,3O-D4-BA, while 3b,7a-
diH-D5-BA is and gives 7aH,3O-D4-BA. MS3 ([M]+! [M-Py]+! ) spectra of (C) 3b,7b-diH-D5-BA and (D) 3b,7a-diH-D5-BA. Aliquots of sample prepared in the presence of
cholesterol oxidase were derivatised with [2H5]GP and those prepared in the absence of cholesterol oxidase with [2H0]GP. Analyte concentrations are given in supplementary
Table S1.
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Fig. 10. Fragmentation of 3b,7a-diH-D5-BA and 3b,7b-diH-D5-BA. Ions of elevated relative abundance in the spectra of 7a- and 7b- epimers are indicated by arrows.
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shoulder is absent in a chromatogram of the authentic 3b,7b-
diHCA(25R) standard, but gives an identical MS3 spectrum. It is
thus assigned to 3b,7b-diHCA(25S).
3.1.4. 3,7-Dihydroxychol-5-en-24-oic and 7-Hydroxy-3-oxochol-4-
en-24-oic acids
After side-chain shortening in the peroxisome C27 7-hydroxy
acids will be converted to their C24 equivalents, we thus screened
for the presence of 3b,7a-dihydroxychol-5-en-24-oic (3b,7a-diH-
D5-BA), 7a-hydroxy-3-oxochol-4-en-24-oic (7aH,3O-D4-BA) and
3b,7b-dihydroxychol-5-en-24-oic (3b,7b-D5-BA) acids in plasma.
7b-Hydroxy-3-oxochol-4-en-24-oic acid should not be formed via
HSD3B7 oxidation due to the presence of a 7b- rather than a 7a-
hydroxy group (Furster et al., 1996). Shown in Fig. 9A and B is the
appropriate RIC for 3b,7-diH-D5-BA and 7aH,3O-D4-BA. Compar-
ison with authentic standards reveals that the ﬁrst pair of peaks in
Fig. 9A correspond to 3b,7b-diH-D5-BA (syn and anti GP con-
formers) while the latter correspond to 3b,7a-diH-D5-BA. As
expected only the latter pair of peaks corresponding to 7aH,3O-
D4-BA are observed in Fig. 9B recorded on the sample prepared in
the absence of cholesterol oxidase. MS3 spectra of the 3b,7b-diH-
D5-BA and 3b,7a-diH-D5-BA epimers are shown in Fig. 9C and D
and as illustrated in Fig. 10 show distinctive features of the
respective 7b- and 7a-epimers.
4. Discussion
It has previously been shown that 7b-HC can be formed not
only ex vivo through autoxidation during sample handling
(Schroepfer, 2000), but also in vivo enzymatically from 7-OC by
HSD11B1 (Hult et al., 2004; Larsson et al., 2007; Mitic et al., 2013)
and perhaps also by free radical reactions from cholesterol
(Murphy and Johnson, 2008) (Fig. 1). In fact, 7b-HC is elevated
in plasma from people with SLOS who also show elevated 7-OC
(Grifﬁths et al., 2016) and also in patients suffering from NPC
disease who similarly show elevated 7-OC in plasma (data not
shown). Interestingly, Alvelius et al. showed that bile acids with a
3b,7b-diH-D5-BA core structure were formed by a patient with
NPC disease (Alvelius et al., 2001), while Evans and Natowicz also
found bile acids probably with the same structure formed by a
patient with SLOS (Natowicz and Evans, 1994). 7b-HC may
represent an early metabolite in the biosynthesis of these acids.
Using our optimised EADSA approach we also ﬁnd comparatively
(to the 7a-epimers) low levels of 7b-HC, 3b,7b-diHCA and 3b,7b-
diH-D5-BA in plasma from healthy individuals, see Supplementary
Table S1 (Abdel-Khalik et al., 2017).
In healthy individuals, we identify four diastereoisomers for
3b,7-diHCA. Besides the 25R epimers of 3b,7a-diHCA and 3b,7b-
diHCA we also identify the corresponding 25S epimers. The
interconversion of 25R and 25S epimers as CoA thioesters is
catalysed by AMACR, the next enzyme in the bile acid biosynthesis
pathway ACOX2 requiring 25S stereochemistry of the substrate
(Russell, 2003). It has recently been reported that a defect in
ACOX2 leads to liver ﬁbrosis, mild ataxia, and cognitive
impairment (Vilarinho et al., 2016). A blockage in the bile acid
biosynthesis pathway at this point would be expected to lead to
elevated levels of both epimers of 3b,7a-diHCA and 3b,7b-diHCA
in plasma which could easily be determined by the EADSA method.
24S-HC is the dominant oxysterol in brain. It is formed by
CYP46A1 mediated oxidation of cholesterol (Russell, 2003). The
origin of the 24R-epimer is less clear. Interestingly, 24R-HC is
present in brain of the CYP46A1 knockout mouse indicating a
source other than a reaction catalysed by CYP46A1 (Meljon et al.,
2014).
5. Conclusions
We describe here how the EADSA method has been optimised
to reveal diastereoisomers of oxysterols, cholestenoic and chol-
enoic acids. Our observations highlight the extreme complexity of
the plasma sterolome.
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